According to Pfizer's Alexandre de Germay, how does China compare with Europe in terms of innovative medicine launches in 2024?

In 2024, 28 innovative medicines were launched from China compared to only 18 from Europe, according to Pfizer Chief International Commercial Officer Alexandre de Germay.

What did Pfizer's Alexandre de Germay state about the speed and cost of clinical development in China versus Europe?

De Germay stated that clinical development can be conducted three times faster in China and at roughly half the cost compared with Europe.

China Outpacing Europe in Drug Innovation and Development, Pfizer Executive Says

Jun 23, 2026

Pfizer executives assert China leads Europe in drug innovation, noting 40% of global oncology trials occur there and more innovative medicines launched in 2024. European stakeholders are now debating strategies to counter this competitive threat alongside the U.S.

reuters

2026-02-12

UK Law Firms Eye Legal Action Against Pfizer Over Contraceptive-Linked Brain Tumours

2026-06-10

Pfizer CEO warns German investment at risk over drug pricing policies

2026-06-18

Pfizer CFO Dave Denton to step down, leave company in August

2026-06-23

China Outpacing Europe in Drug Innovation and Development, Pfizer Executive Says

2026-07-10

Polish Air Traffic Control Faces Funding Freeze Over COVID Vaccine Ruling